Technical Analysis for DXR - Daxor Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.10% | |
| Reversal New Highs Setup | Bullish Swing Setup | 0.10% | |
| Outside Day | Range Expansion | 0.10% | |
| Overbought Stochastic | Strength | 0.10% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 13 hours ago |
| Reversal New Highs Entry | about 13 hours ago |
| Non-ADX 1,2,3,4 Pullback Entry | about 13 hours ago |
| Rose Above Previous Day's High | about 13 hours ago |
| 3x Volume Pace | about 13 hours ago |
Free Daily (Stock) Chart Reading
Daxor Corporation Description
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disorders Hypertension Heart Failure Hematology Anemia Radiology Blood Transfusion Medicine Red Blood Cell Science Kidney Failure Blood Transfusion Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.3 |
| 52 Week Low | 7.11 |
| Average Volume | 2,637 |
| 200-Day Moving Average | 8.95 |
| 50-Day Moving Average | 8.60 |
| 20-Day Moving Average | 9.20 |
| 10-Day Moving Average | 9.59 |
| Average True Range | 0.33 |
| RSI (14) | 65.75 |
| ADX | 10.43 |
| +DI | 28.01 |
| -DI | 23.08 |
| Chandelier Exit (Long, 3 ATRs) | 8.90 |
| Chandelier Exit (Short, 3 ATRs) | 9.02 |
| Upper Bollinger Bands | 10.10 |
| Lower Bollinger Band | 8.31 |
| Percent B (%b) | 0.8 |
| BandWidth | 19.48 |
| MACD Line | 0.34 |
| MACD Signal Line | 0.31 |
| MACD Histogram | 0.0314 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.20 | ||||
| Resistance 3 (R3) | 10.20 | 10.05 | 10.13 | ||
| Resistance 2 (R2) | 10.05 | 9.94 | 10.05 | 10.10 | |
| Resistance 1 (R1) | 9.90 | 9.86 | 9.98 | 9.90 | 10.07 |
| Pivot Point | 9.75 | 9.75 | 9.79 | 9.75 | 9.75 |
| Support 1 (S1) | 9.60 | 9.64 | 9.68 | 9.60 | 9.43 |
| Support 2 (S2) | 9.45 | 9.56 | 9.45 | 9.40 | |
| Support 3 (S3) | 9.30 | 9.45 | 9.38 | ||
| Support 4 (S4) | 9.30 |
